IN THE NEWS

THE LATEST NEWS

Panel Discussion | Why the FDA will bet more on in silico simulations to trigger better success rates for NDAs

BIO 2022: Push to model disease biology advancing, but slowly

Scrip Asks…What Does 2022 Hold For Biopharma? Part 5: Clinical Trials

12 Tech Trends To Watch Closely In 2022

In Silico in Sight as Biopharma Game-Changer

GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design

GNS Healthcare Launches Computer Model of Disease Progression, Treatment Responses in Myeloma

Wall Street Journal Covers GNS Launch of Gemini

Cambia’s Peggy Maguire: Palliative Care Supports Economic Sustainability

Study: If more Wisconsin doctors provided better care, key medical procedures would cost 30% less